This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

pms-Escitalopram (2017-05-09)

Starting date:
May 9, 2017
Posting date:
May 19, 2017
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-63754

Affected Products

A. pms-Escitalopram 10 mg

B. pms-Escitalopram 20

Reason

Out of specification for degradation product during stability tests.

Depth of distribution

Retailers across Canada

Affected products

A. pms-Escitalopram 10 mg

DIN, NPN, DIN-HIM
DIN 02303949
Dosage form

Tablet

Strength

10 mg

Lot or serial number

499927
499956
602153
602154

Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

B. pms-Escitalopram 20 mg

DIN, NPN, DIN-HIM
DIN 02303965
Dosage form

Tablet

Strength

20 mg

Lot or serial number

488029
499902
600408

Companies
Recalling Firm
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA
Marketing Authorization Holder
Pharmascience Inc.
100, 6111 Royalmount Avenue
Montreal
H4P 2T4
Quebec
CANADA

Date modified: